CIK 0001641489 · Non-accelerated filer<br>Smaller reporting company
vTv Therapeutics Inc.
Sign in to watch- Ticker
- VTVT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473916571
- Phone
- 336-841-0300
- Business address
- 3980 PREMIER DR, SUITE 310, HIGH POINT, NC, 27265
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 30,000 shares at an average $6.26 ($187,821)
- 4 Open-market buy 10% owner bought 40,000 shares at an average $6.04 ($241,406)
- 4 Open-market buy Director bought 5,000 shares at $6.62 ($33,117)
- 4 Open-market buy 10% owner bought 24,000 shares at $6.82 ($163,567)
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Unregistered share sale
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- SC 13D Stake Beneficial Ownership Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy 10% owner bought 40,000 shares at an average $8.81 ($352,367)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 100,000 shares at an average $10.00 ($1,000,021)
- 4 Open-market buy Director bought 15,000 shares at $15.00 ($225,000)
Page 28 of 31 · 602 filings